Melatonin use for SARS‐CoV‐2 infection: Time to diversify the treatment portfolio

Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection

(2022) Russel J. Reiter et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Efficacy of melatonin in the treatment of patients with COVID‐19: A systematic review and meta‐analysis of randomized controlled trials

(2022) Shao‐Huan Lan et al.   JOURNAL OF MEDICAL VIROLOGY

Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial

(2021) Gholamreza Farnoosh et al.   ARCHIVES OF MEDICAL RESEARCH

What if melatonin could help COVID-19 severe patients?

(2021) Miguel Ángel Sánchez-González et al.   Journal of Clinical Sleep Medicine

Melatonin effects on sleep quality and outcomes of COVID‐19 patients: An open‐label, randomized, controlled trial

(2021) Seyed Abbas Mousavi et al.   JOURNAL OF MEDICAL VIROLOGY

The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients

(2021) Zainab Thanon Hasan et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Targeting Host Defense System and Rescuing Compromised Mitochondria to Increase Tolerance against Pathogens by Melatonin May Impact Outcome of Deadly Virus Infection Pertinent to COVID-19

(2020) Dun-Xian Tan et al.   MOLECULES

Beneficial actions of melatonin in the management of viral infections: a new use for this “molecular handyman”?

(2012) Jose Antonio Boga et al.   REVIEWS IN MEDICAL VIROLOGY